RA CAPITAL MANAGEMENT, L.P.
董事
RA Capital Management, L.P. is a multi-stage investment management firm and registered investment adviser that acts as a significant institutional investor and corporate insider in the biopharmaceutical and life sciences sectors, including as a reporting insider at Artiva Biotherapeutics, Inc. in connection with board representation.[[1]](https://en.wikipedia.org/wiki/RA_Capital_Management)[[3]](https://www.bloomberg.com/profile/company/1894965D:US)[[4]](https://ir.climbbio.com/static-files/6fa13e09-54bd-4673-9ae2-d3bbb1a56f73) Founded in 2002 by Richard Aldrich and Peter Kolchinsky, the firm is based in the Berkeley Building in Boston, Massachusetts, and manages a diversified platform spanning hedge fund, venture capital, and private equity strategies focused on healthcare, biotechnology, and related industries.[[1]](https://en.wikipedia.org/wiki/RA_Capital_Management)[[2]](https://www.racap.com/about-us)[[3]](https://www.bloomberg.com/profile/company/1894965D:US)
RA Capital Management, L.P. specializes in evidence‑based investing in public and private healthcare and life science companies developing drugs, medical devices, diagnostics, services, and research tools, with a global portfolio that covers most therapeutic areas from discovery through commercialization.[[2]](https://www.racap.com/about-us)[[5]](https://www.racap.com)[[8]](https://www.racap.com/venture/our-portfolio) The firm also has a growing interest in climate and sustainability technologies and is led by Managing Partners Peter Kolchinsky and Rajeev Shah, who oversee its investment activities and company‑building efforts.[[1]](https://en.wikipedia.org/wiki/RA_Capital_Management)[[2]](https://www.racap.com/about-us)[[4]](https://ir.climbbio.com/static-files/6fa13e09-54bd-4673-9ae2-d3bbb1a56f73)[[6]](https://www.racap.com/about-us/our-team)[[8]](https://www.racap.com/venture/our-portfolio) As disclosed in SEC filings, RA Capital Management, L.P. serves as investment manager and adviser to affiliated funds that hold significant positions in biotechnology issuers, which underlies its status as a corporate insider when those funds are represented on company boards.[[4]](https://ir.climbbio.com/static-files/6fa13e09-54bd-4673-9ae2-d3bbb1a56f73)[[7]](https://whalewisdom.com/filer/ra-capital-management-llc)
查看完整内部人档案 →